The Somerset Strategy: How a NJ Cancer Center Lures Patients from NYC

SOMERSET, NJ – June 29, 2026 – For 28 days, Tim, a retired New York City prosecutor, made a journey that defies conventional wisdom. He bypassed the world-renowned medical institutions of his home city, crossing the bridge from Staten Island into Central New Jersey. His destination: ProCure Proton Therapy Center in Somerset. His story is more than a patient testimonial; it's a case study in the evolving economics of healthcare, where specialized technology and personalized service are creating new competitive dynamics that challenge the dominance of metropolitan medical giants.

At first glance, the decision seems counterintuitive. Why travel for daily treatments when some of the world's best hospitals are in your backyard? The answer, it turns out, lies in a powerful combination of physician trust, technological promise, and a patient experience meticulously crafted to stand apart. This is the story behind the numbers, revealing why the future of market performance in healthcare may belong to those who master the niche.

The Patient's Calculus

Tim's journey began not with a billboard or a flashy ad, but with a trusted recommendation from his primary care physician. After a prostate cancer diagnosis, he was steered toward ProCure and its Medical Director, Dr. Brian Chon. The deciding factor wasn't a brochure, but an 80-minute consultation that transformed complex medical information into a clear, confident path forward.

"I went home knowing that ProCure was the right choice," Tim said, as noted in a recent company statement. "Dr. Chon made it easy to understand my treatment options, answered every question, and gave me confidence in the path forward."

This experience highlights a critical shift in patient behavior. In an age of information overload, patients are becoming sophisticated consumers, weighing not just institutional reputation but the quality of direct interaction and personalized care. Tim's praise for Dr. Chon's continued involvement throughout his 28 treatment sessions—a stark contrast to the common feeling of being 'handed off' in larger systems—is a key data point. It signals that in the modern healthcare market, the perception of being a number is a significant liability. ProCure's model, which emphasizes consistent, high-touch interaction with senior medical staff, turns this dynamic into a competitive advantage.

The High-Tech, High-Cost Bet on Protons

The allure of ProCure isn't just about customer service; it's built on a foundation of advanced technology. As the first facility of its kind in the tri-state area when it opened in March 2012, the center staked its future on proton therapy, a highly precise form of radiation.

Unlike traditional X-ray (photon) radiation, which passes through the body and exits on the other side, protons can be programmed to stop and deposit their cancer-killing energy directly within a tumor. This phenomenon, known as the Bragg peak, is the technology's core value proposition. For a prostate cancer patient like Tim, this means delivering a potent dose to the cancer while potentially sparing the nearby bladder and rectum from up to 60% of the radiation exposure. The potential benefits are tangible: a lower risk of long-term side effects like incontinence and gastrointestinal issues.

The clinical results are compelling. Studies have shown five-year, cancer-free survival rates as high as 99% for low- and intermediate-risk prostate cancer treated with proton therapy. But this precision comes at a price. With treatment costs ranging from $30,000 to $120,000, proton therapy is significantly more expensive than conventional methods, leading to complex battles with insurance providers over medical necessity. Yet, for patients like Tim, the equation is clear: the upfront investment and travel burden are a worthwhile trade-off for a non-surgical option that promises a better quality of life post-treatment.

The Tri-State Cancer Corridor

For seven years, ProCure enjoyed its status as the region's sole proton provider. That changed in 2019 with the opening of the New York Proton Center (NYPC), a massive consortium backed by healthcare titans Memorial Sloan Kettering Cancer Center, Montefiore Health System, and NYU Langone Health. Suddenly, the pioneer had a formidable competitor in its primary market.

Yet, ProCure has not only survived but thrived, recently celebrating the treatment of its 8,000th patient. Its strategy offers a playbook for how specialized centers can compete with scale. By affiliating with the expansive Hackensack Meridian Health network and recruiting top-tier physicians like Dr. Timothy H. Chen, the center has solidified its clinical credibility. It leverages its decade-plus of operational experience and patient outcome data as a key differentiator.

As Dr. Chon states, "Patients come to ProCure from across the region, other states, and even outside the U.S. because exceptional cancer care is worth the trip." This isn't just marketing rhetoric; it's a statement of a business model that has successfully uncoupled premier medical care from geography. By proving it can offer something the giants in the city cannot—or at least, are not perceived to—ProCure attracts a steady flow of patients willing to vote with their feet, and their cars.

Service as a Strategic Moat

In a market where the core technology is no longer exclusive, ProCure's enduring success hinges on building a strategic moat around the patient experience. The initial 80-minute consultation is the first brick in this fortress. The continued, personal involvement of the medical director is another.

Beyond the clinical, the center has invested heavily in the logistics of care, especially for its traveling patient base. The recent expansion of ancillary services, including a licensed Social Worker, a registered dietician, and concierge resources for transportation and lodging, demonstrates a deep understanding of its customers' needs. When a patient is undergoing a multi-week treatment far from home, these support systems are not amenities; they are essential components of the care package.

This holistic approach transforms the center from a mere provider of a medical procedure into a comprehensive partner in a patient's cancer journey. It's a high-investment strategy, but one that fosters intense loyalty and generates the most powerful form of marketing: the word-of-mouth recommendation that brought Tim across the bridge in the first place. This focus on the complete patient journey shows how industrial transformation in healthcare is not just about new machines, but about redesigning the entire service delivery system around the end user.